Infiltrating lobular carcinoma of the br
โ
Xavier Sastre-Garau; Michel Jouve; Bernard Asselain; Anne Vincent-Salomon; Phili
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 669 KB
## BACKGROUND. The clinicopathologic features of infiltrating lobular carcinoma (ILC), which represents 5% to 15% of all breast cancers, are still controversial. In particular, the high frequency of multicentric lesions has led to questioning of the effectiveness of conservative treatment for this